Install
FirstWord
- 112articles · 30d
- 5+ hour agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 13avg words
- Medical 92
- Health 75
- Health & Wellness 68
- Business & Industrial 39
- Economy, Business & Finance 25
- Finance & Business 16
- Science & Technology 10
- News 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Spotlight On: Ivonescimab beats expectations to revive practice-changing hopes in NSCLC
5+ hour, 24+ min ago (13+ words) FirstWord Pharma...
WCLC26: Ivonescimab delivers 27% lower risk of death in Chinese NSCLC study
8+ hour, 19+ min ago (14+ words) FirstWord Pharma...
Spotlight On: SERENA-4 miss raises broader concerns over AZ's pipeline
11+ hour, 53+ min ago (12+ words) FirstWord Pharma...
WCLC26: GSK's ris-rez cuts death risk 54% in China Phase III lung cancer trial
12+ hour, 33+ min ago (16+ words) FirstWord Pharma...
AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial
21+ hour, 43+ min ago (12+ words) firstwordpharma.com...
Vital Signs: Tracking the trials and tribulations ahead for CVOTs
3+ day, 6+ hour ago (11+ words) firstwordpharma.com...
AbbVie aims to expand Qulipta's label into new migraine market
3+ day, 4+ hour ago (12+ words) FirstWord PHARMA...
Animal data trigger enrollment pause in Biohaven's epilepsy study
3+ day, 8+ hour ago (11+ words) FirstWord PHARMA...
NodThera rebrands as Rezera, charts registrational path for PAD drug
3+ day, 21+ hour ago (12+ words) FirstWord Pharma...
Encoded pulls in $275M for pivotal study of Dravet gene therapy
4+ day, 4+ hour ago (13+ words) FirstWord PHARMA...